Boston University researchers claimed that they have developed a new system of non or minimal invasive technique that identifies the earlier stages of lung cancer which in turn offer effective treatment and increased survival rate.
There may be a cheap, easy way to detect lung cancer early, researchers say -- by picking a patient's nose.
The researchers examined the epithelial cells of nose and it shares the same genetic markers which identify people with lung cancer.
A simple test using cells swabbed from the inside of the nose may help detect lung cancer in its earliest stages, when it's most treatable.
Boston University researchers collected interior nose skin cells from 33 smokers being tested for lung cancer. 11 were found to have benign disease and 22 had cancer.
The new development provides the researchers to scrap or brush epithelial cells from any side of the interior nose determine the lung cancer by putting the cells in microarrays, a process enables the researchers to study gene expression changes.
After analyzing the cells, the researchers found there were 170 different genes whose level of activity was different, depending on whether or not a patient had lung cancer.
Lung cancer is the most common cause of cancer mortality, with an average five-year survival rate of only 15 percent.
However, survival rates are highly dependent upon how advanced the cancer is when detected.
There may be a cheap, easy way to detect lung cancer early, researchers say -- by picking a patient's nose.
The researchers examined the epithelial cells of nose and it shares the same genetic markers which identify people with lung cancer.
A simple test using cells swabbed from the inside of the nose may help detect lung cancer in its earliest stages, when it's most treatable.
Boston University researchers collected interior nose skin cells from 33 smokers being tested for lung cancer. 11 were found to have benign disease and 22 had cancer.
The new development provides the researchers to scrap or brush epithelial cells from any side of the interior nose determine the lung cancer by putting the cells in microarrays, a process enables the researchers to study gene expression changes.
After analyzing the cells, the researchers found there were 170 different genes whose level of activity was different, depending on whether or not a patient had lung cancer.
Lung cancer is the most common cause of cancer mortality, with an average five-year survival rate of only 15 percent.
However, survival rates are highly dependent upon how advanced the cancer is when detected.
No comments:
Post a Comment